Mancuso M, Nardini M, Micheli D, Rocchi A, Nesti C, Giglioli N J, Petrozzi L, Rossi C, Ceravolo R, Bacci A, Choub A, Ricci G, Tognoni G, Manca M L, Siciliano G, Murri L
Department of Neuroscience, Neurological Clinic, University of Pisa, Via Roma 67, I-56126, Pisa, Italy.
Neurol Sci. 2007 Jun;28(3):142-7. doi: 10.1007/s10072-007-0807-z. Epub 2007 Jun 30.
Mitochondrial DNA (mtDNA) haplogroup-specific polymorphisms were previously related to several neurodegenerative diseases, including Alzheimer's disease (AD). However, the precise role of mtDNA haplogroups in the neurodegenerative cascade leading to AD is still unclear. In this work we have genotyped predefined European mtDNA haplogroups in 209 patients with AD and 191 matched controls. In order to minimise the risk of "genetic contamination", which could lead to false associations between gene markers and disease, we were careful to enrol in the study only patients and controls of clear Tuscan origin (with at least three generations of Tuscanborn relatives). The frequency of the haplogroups did not differ between the two groups, and no correlation with gender, ApoE genotype, age of onset or disease status was observed. Further studies will be required to define the contribution of mtDNA haplogroups, if any, to the pathogenesis of AD. A correct population selection, in order to minimise the risk of genetic contamination, is essential in these studies.
线粒体DNA(mtDNA)单倍群特异性多态性先前与包括阿尔茨海默病(AD)在内的几种神经退行性疾病相关。然而,mtDNA单倍群在导致AD的神经退行性级联反应中的精确作用仍不清楚。在这项研究中,我们对209例AD患者和191例匹配对照进行了预定义欧洲mtDNA单倍群的基因分型。为了将可能导致基因标记与疾病之间出现错误关联的“基因污染”风险降至最低,我们在研究中谨慎地仅纳入了明确来自托斯卡纳地区(至少有三代托斯卡纳出生亲属)的患者和对照。两组之间单倍群的频率没有差异,并且未观察到与性别、载脂蛋白E基因型、发病年龄或疾病状态存在相关性。需要进一步的研究来确定mtDNA单倍群(如果有的话)对AD发病机制的贡献。为了将基因污染风险降至最低,正确的人群选择在这些研究中至关重要。